← All trials
NCT00423254
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2007
- Primary completion
- Sep 1, 2009
- Completion date
- Nov 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 12
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- MannKind CorpLead sponsor
Drugs studied
Indications studied
- Biliary Tract Neoplasms
- Breast Neoplasms
- Carcinoma
- Uterine Cervical Neoplasms
- Esophageal Neoplasms
- Gallbladder Neoplasms
- Kidney Diseases
- Liver Neoplasms
- Melanoma
- Mesothelioma
- Ovarian Diseases
- Pancreatic Neoplasms
- Prostate
- Rectal Neoplasms
- Sarcoma
- Osteosarcoma
- Stomach Neoplasms
- Testicular Neoplasms
- Thyroid Neoplasms
- Colorectal Neoplasms
- Endometrial Neoplasms
- Neuroendocrine Tumors
- Small Cell Lung Carcinoma
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.